: Omeros stock price target cut to $13 from $25 at UBS

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Omeros Corp.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply